Stay updated with breaking news from Accessed May. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Pirfenidone to its oral solid products portfolio. The new drug is...
Takeda UK Ltd. is pleased to announce that NICE has recommended the use of Revestive ? (teduglutide) once daily subcutaneous injection as an option for people living with Short Bowel Syndrome
It is imperative that the United States continues to assist its smaller neighbors with initiatives to reduce the violence [in the Anglophone Caribbean].
The FDA has expanded the approval of Evrysdi to include infants less than 2 months of age with spinal muscular atrophy.
An at-home test designed to help individuals identify birth control options that may limit potential side effects has been made available by adyn.